RxDoctor Payments Data

James Hyatt, MD

Family Medicine · Thibodaux, LANPI 1891878427

Payments from drug & device makers

$6,815in general payments, 2019–2025

Across 94 payments — averaging $72.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Braeburn Inc.$4K
  • Indivior Inc.$567
  • Alkermes, Inc.$357
  • Stryker$250
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$226
  • Neurocrine Biosciences, Inc.$185
  • plus $787 from 15 others

What the payments were for

  • Speaking & faculty fees$2,60038%
  • Travel & lodging$1,13217%
  • Food & beverage$3,05245%
  • Education$300%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,815 in reported general payments places this provider in the 85th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$2,723
Medicare patients
13
Services billed
33

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrixadiBuprenorphine62$104,969
SublocadeBuprenorphine20$41,772
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl136$19,886
SuboxoneBuprenorphine Hcl/Naloxone Hcl23$11,947
LinzessLinaclotide12$6,377
Naloxone Hcl11$761
Naltrexone Hcl11$373
Lidocaine HclLidocaine Hcl/Pf13$25

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Braeburn Inc.Brixadi$4,443$104,96962 claims
Indivior Inc.Sublocade, Suboxone$567$53,71943 claims
Hikma Pharmaceuticals USABuprenorphine-Naloxone$14$19,886136 claims
AbbVieLinzess$136$6,37712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Thibodaux

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →